Computational studies by molecular docking of some antiviral drugs with COVID-19 receptors are an approach to medication for COVID-19
The COVID-19 outbreak is a matter of concern worldwide due to unavailability of promising treatment comprising medication or vaccination till date. The discovery of antiviral drug is of immense importance in the existing spread of novel coronavirus. The goal of the present study was to evolve an opp...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
De Gruyter
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6b2a4c7c5e3943838b978f6fccbc2b27 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:6b2a4c7c5e3943838b978f6fccbc2b27 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:6b2a4c7c5e3943838b978f6fccbc2b272021-12-05T14:10:43ZComputational studies by molecular docking of some antiviral drugs with COVID-19 receptors are an approach to medication for COVID-192391-542010.1515/chem-2021-0024https://doaj.org/article/6b2a4c7c5e3943838b978f6fccbc2b272021-03-01T00:00:00Zhttps://doi.org/10.1515/chem-2021-0024https://doaj.org/toc/2391-5420The COVID-19 outbreak is a matter of concern worldwide due to unavailability of promising treatment comprising medication or vaccination till date. The discovery of antiviral drug is of immense importance in the existing spread of novel coronavirus. The goal of the present study was to evolve an opposite antiviral drug against the novel COVID-19 virus. A directly succeeding perspective would be to use the prevailing influential drugs from several antimicrobial and chemotherapeutic agents. The encouraging approach is to identify promising drug molecules and compounds through virtual screening via molecular docking of FDA-approved drugs and some previously synthesized pyridone and coumarin derivatives for probable therapeutic outcome. In this conceptual milieu, an effort has been made to propose a computational in silico relationship among FDA-approved drugs and coronavirus-associated receptors and proteins. The study results were evaluated on the basis of a dock score by using molecular operating environment. Out of 15 compounds screened, the compounds with the best docking scores toward their targets was 3d. Therefore, compound 3d deserves further investigations and clinical trials as a possible therapeutic inhibitor of the COVID-19 caused by the novel SARS-CoV-2.Abdellatiif Magda H.Ali AmenaAli AbuzerHussien Mostafa A.De Gruyterarticlemoemolecular dockingcovid-19pyridonescoumarinChemistryQD1-999ENOpen Chemistry, Vol 19, Iss 1, Pp 245-264 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
moe molecular docking covid-19 pyridones coumarin Chemistry QD1-999 |
spellingShingle |
moe molecular docking covid-19 pyridones coumarin Chemistry QD1-999 Abdellatiif Magda H. Ali Amena Ali Abuzer Hussien Mostafa A. Computational studies by molecular docking of some antiviral drugs with COVID-19 receptors are an approach to medication for COVID-19 |
description |
The COVID-19 outbreak is a matter of concern worldwide due to unavailability of promising treatment comprising medication or vaccination till date. The discovery of antiviral drug is of immense importance in the existing spread of novel coronavirus. The goal of the present study was to evolve an opposite antiviral drug against the novel COVID-19 virus. A directly succeeding perspective would be to use the prevailing influential drugs from several antimicrobial and chemotherapeutic agents. The encouraging approach is to identify promising drug molecules and compounds through virtual screening via molecular docking of FDA-approved drugs and some previously synthesized pyridone and coumarin derivatives for probable therapeutic outcome. In this conceptual milieu, an effort has been made to propose a computational in silico relationship among FDA-approved drugs and coronavirus-associated receptors and proteins. The study results were evaluated on the basis of a dock score by using molecular operating environment. Out of 15 compounds screened, the compounds with the best docking scores toward their targets was 3d. Therefore, compound 3d deserves further investigations and clinical trials as a possible therapeutic inhibitor of the COVID-19 caused by the novel SARS-CoV-2. |
format |
article |
author |
Abdellatiif Magda H. Ali Amena Ali Abuzer Hussien Mostafa A. |
author_facet |
Abdellatiif Magda H. Ali Amena Ali Abuzer Hussien Mostafa A. |
author_sort |
Abdellatiif Magda H. |
title |
Computational studies by molecular docking of some antiviral drugs with COVID-19 receptors are an approach to medication for COVID-19 |
title_short |
Computational studies by molecular docking of some antiviral drugs with COVID-19 receptors are an approach to medication for COVID-19 |
title_full |
Computational studies by molecular docking of some antiviral drugs with COVID-19 receptors are an approach to medication for COVID-19 |
title_fullStr |
Computational studies by molecular docking of some antiviral drugs with COVID-19 receptors are an approach to medication for COVID-19 |
title_full_unstemmed |
Computational studies by molecular docking of some antiviral drugs with COVID-19 receptors are an approach to medication for COVID-19 |
title_sort |
computational studies by molecular docking of some antiviral drugs with covid-19 receptors are an approach to medication for covid-19 |
publisher |
De Gruyter |
publishDate |
2021 |
url |
https://doaj.org/article/6b2a4c7c5e3943838b978f6fccbc2b27 |
work_keys_str_mv |
AT abdellatiifmagdah computationalstudiesbymoleculardockingofsomeantiviraldrugswithcovid19receptorsareanapproachtomedicationforcovid19 AT aliamena computationalstudiesbymoleculardockingofsomeantiviraldrugswithcovid19receptorsareanapproachtomedicationforcovid19 AT aliabuzer computationalstudiesbymoleculardockingofsomeantiviraldrugswithcovid19receptorsareanapproachtomedicationforcovid19 AT hussienmostafaa computationalstudiesbymoleculardockingofsomeantiviraldrugswithcovid19receptorsareanapproachtomedicationforcovid19 |
_version_ |
1718371790465531904 |